We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Support from existing investors including Redmile Group, Invus, Sofinnova Partners and a large investment management firm Financing will enable the Company to extend its cash runway through the...
Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and...
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN), société de biotechnologie pionnière au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer...
Milestone achieved for SENS-501 gene therapy program with Clinical Trial Application approval in Europe (France as first country) Communication on first patient expected in H2 2024 GJB2 gene...
Presence of SENS-401 in the perilymph is confirmed in 100% of the patients sampled following cochlear implantation at levels compatible with potential therapeutic efficacy Regulatory News:...
Regulatory News: Sensorion (FR0012596468 – ALSEN), société de biotechnologie pionnière au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.022 | -3.1339031339 | 0.702 | 0.74 | 0.676 | 28062 | 0.70874688 | DE |
4 | -0.061 | -8.23211875843 | 0.741 | 0.77 | 0.676 | 40448 | 0.72741184 | DE |
12 | 0.16 | 30.7692307692 | 0.52 | 1.04 | 0.51 | 126171 | 0.79986689 | DE |
26 | 0.15 | 28.3018867925 | 0.53 | 1.04 | 0.403 | 90360 | 0.69637004 | DE |
52 | 0.358 | 111.180124224 | 0.322 | 1.04 | 0.26 | 87733 | 0.6150838 | DE |
156 | -1.62 | -70.4347826087 | 2.3 | 2.395 | 0.26 | 81716 | 0.86665608 | DE |
260 | -0.624 | -47.8527607362 | 1.304 | 2.88 | 0.26 | 90158 | 1.14462353 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions